- Home
- HERE vs YARW Comparison
HERE vs YARW Comparison
Compare HERE & YARW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HERE | YARW |
|---|---|---|
| Founded | 2019 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.1M | 114.6M |
| IPO Year | 2022 | 2017 |
Fundamental Metrics
Financial Performance| Metric | HERE | YARW |
|---|---|---|
| Price | $1.90 | $30.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.0K | ★ 30.4K |
| Earning Date | 06-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $79.29 | N/A |
| P/E Ratio | $2.83 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $27.31 |
| 52 Week High | $5.80 | $44.28 |
Technical Indicators
Market Signals| Indicator | HERE | YARW |
|---|---|---|
| Relative Strength Index (RSI) | 54.23 | 35.81 |
| Support Level | $1.81 | $27.31 |
| Resistance Level | $1.95 | $43.96 |
| Average True Range (ATR) | 0.05 | 3.77 |
| MACD | 0.01 | -1.28 |
| Stochastic Oscillator | 89.03 | 10.85 |
Price Performance
Historical ComparisonAbout HERE Here Group Limited American Depositary Shares
Here Group Ltd is dedicated to creating collectible pop toys that evoke joy and emotional resonance. The group design and compelling storytelling, which provide users with a collecting experience that blends artistic value with emotional warmth, continuously convey a joyful and immersive brand culture. Adhering to the brand philosophy of joy, integrity, wonder, and co-creation, the company is building a vibrant ecosystem connecting creativity and emotion, working hand-in-hand with overall toy enthusiasts to create, share, and transmit dreams.
About YARW Yarrow Bioscience Inc. Common Stock
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.